Monday, 24 Jun 2019

Gout/Crystal

Datesort ascending Type Title Save
21 Jun 2019 ACR Video Brian Lamoreaux on higher comorbidities in Gout
21 Jun 2019 ACR Video Dr. Peter Lipsky - 1 Million #Gout Patients & who cares for them
21 Jun 2019 ACR Video Dr Alex So Reflects on Days 1-3 Gout Highlights at EULAR 2019
19 Jun 2019 News Allopurinol Fails to Curtail Hypertension
10 Jun 2019 News Updated 2018 EULAR Recommendations for the Diagnosis of Gout
10 Jun 2019 News Excess Non-CV Mortality Persists in Gout
06 Jun 2019 Social The overall prevalence of gout among US adults is 3.9%, affecting 9.2 million people. Hyperuricaemia prevalence is 14.6% - affecting 32.5 million in the US. Data from NHANES NHANES 2015–16 https://t.co/3g05GmUDUA
04 Jun 2019 Social UK Clinical Practice Database matched 62,234 pts with and without gout showing more venous thromboembolic events in gout (0.373 vs 0.27 per 100 Pt-yrs) (aHR 1.25, 95% CI 1.15–1.35) - not affected by ULT & not significant while in hospital (aHR 1.01) https://t.co/XrInEwckez
03 Jun 2019 News Despite Gout Numbers and Flares, Allopurinol is Underutilized
31 May 2019 Social Korean National Health Insurance data compared the risk of CV events in 39,640 gout pts starting allopurinol or febuxostat. MACE incidence was 1.89 vs 1.84/100PY (HR 1.09; 0.90, 1.32) Thus, no significant difference in CV risk with these agents in Asians https://t.co/l316siAqd8
29 May 2019 Social Risk factors for gouty tophi that ulcerate include: glucocorticoid overuse, tophi duration, and the number of tophi. Based on a chinese study of 105 tophaceous patients of whom 33 developed ulcerations https://t.co/rzYTFCb5jk
17 May 2019 Social DECT is most accurate in diagnosing established gout - review of 10 studies shows a pooled (95% CI) sensitivity of 0.81 (0.77, 0.86) and specificity of 0.91 (0.85, 0.95), respectively. W/ short disease duration (⩽6 wks), sensitivity 0.55 and spec 0.89 https://t.co/DOdejOZGcv
16 May 2019 News Coexistent Gout Increases Risk in Rheumatoid Arthritis
16 May 2019 Social Medicare analysis shows Gout patients are twice as likely to have chronic pain (HR 2.02; 95% CI 1.98-2.05) and use of allopurinol or febuxostat was associated with a lower risk of chronic pain (HR 0.72-0.79) https://t.co/xW5rVPyC69
15 May 2019 News Less Structural Damage with T2T in Gout
10 May 2019 Social Initiating Urate Lowering Therapy (ULT) in 75 #Gout patients was associated with a 48% gout flare rate (within 3 mos of ULT). Risk factors include CRP >30mg/L, no prophylaxis (NSAID, colchicine) https://t.co/0oqnMgNVzX
02 May 2019 News Ideal Outcomes are Seldom Achieved in Gout
01 May 2019 News Omega-3 Rich Fish Lowers Gout Flares
26 Apr 2019 Social Comparing nearly 230,000 Taiwanese with and without gout shows gout pts have more psoriasis (1.6% vs 1.1%; adjusted OR 1.30; 1.20-1.42) and psoriatic arthritis (0.3% v 0.1%; aOR 2.50; 1.95-3.22). https://t.co/c1ZVy5E6vk
19 Apr 2019 Social RheumNow Podcast is Up! Eat Your Veggies and more about drug prices, gout, tapering, PSS mortality, insoles, Temporal arter bx & more. https://t.co/3gmVISUv9E or listen to the podcast on iTunes or SoundCloud here>> https://t.co/URNYnLd7Yi